已收盤 05-08 16:00:00 美东时间
+0.035
+3.71%
PatentVest's report highlights the rapid expansion of triple-agonist programs in obesity therapeutics, with 27 global projects across major pharma companies and emerging biotechs. The study emphasizes the shift from clinical outcomes to intellectual property strategies, receptor engineering, and delivery systems as key factors shaping the next phase of competition. China is a significant player in this pipeline expansion. Companies like Eli Lilly...
05-08 14:30
今日重点评级关注:Canaccord Genuity:维持Generac控股"买入"评级,目标价从275美元升至300美元;Oppenheimer:维持Biogen"跑赢大市"评级,目标价从250美元升至275美元
04-02 16:17
今日重点评级关注:花旗:维持Biomea Fusion"买入"评级,目标价从6美元升至7美元;Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.75美元升至8.25美元
03-30 11:49
HC Wainwright & Co. analyst Brandon Folkes reiterates Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and maintains $11 price target.
03-27 18:50
Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 22.81 percent. This is a 74.07 percent increase over losses of $(0.27) per
03-27 04:06
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Southland Holdings, Inc.涨49.24%;Tempest Therapeutics, Inc.涨36.21%;Rani Therapeutics涨22.81%
03-26 15:01
Southland Holdings, Inc.涨53.03%;Navan, Inc. Class A涨26.45%;Rani Therapeutics涨22.81%
03-26 13:03